0001567619-22-000568.txt : 20220105 0001567619-22-000568.hdr.sgml : 20220105 20220105164705 ACCESSION NUMBER: 0001567619-22-000568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dupont Jakob CENTRAL INDEX KEY: 0001553335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36548 FILM NUMBER: 22511882 MAIL ADDRESS: STREET 1: C/O ONCOMED PHARMACEUTICALS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001604464 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 460920988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-278-8930 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc1.xml FORM 4 X0306 4 2022-01-03 0 0001604464 Atara Biotherapeutics, Inc. ATRA 0001553335 Dupont Jakob C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, Head of R&D Common Stock 2022-01-03 4 M 0 5000 9.58 A 95594 D Common Stock 2022-01-03 4 S 0 5000 16.01 D 90594 D Employee Stock Option (Right to Buy) 9.58 2022-01-03 4 M 0 5000 0 D 2030-05-13 Common Stock 5000 262500 D Transaction pursuant to Rule 10b5-1 Plan adopted September 3, 2021. 25% of the shares subject to the option vested on May 14, 2021 and the remaining shares vest in equal monthly installments over the following 36 months, subject to the reporting person's continuous service. /s/ David Tucker, Attorney-in-Fact for Jakob Dupont 2022-01-05